Cargando…
Driving neural regeneration through the mammalian target of rapamycin
Neurodegenerative disorders affect more than 30 million individuals throughout the world and lead to significant disability as well as death. These statistics will increase almost exponentially as the lifespan and age of individuals increase globally and individuals become more susceptible to acute...
Autor principal: | Maiese, Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192939/ https://www.ncbi.nlm.nih.gov/pubmed/25317149 http://dx.doi.org/10.4103/1673-5374.139453 |
Ejemplares similares
-
Mammalian target of rapamycin signaling in diabetic cardiovascular disease
por: Chong, Zhao Zhong, et al.
Publicado: (2012) -
Mammalian Target of Rapamycin: Hitting the Bull's-Eye for Neurological Disorders
por: Chong, Zhao Zhong, et al.
Publicado: (2010) -
Novel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic disease
por: Maiese, Kenneth
Publicado: (2015) -
Nanobiomaterials for neural regeneration
por: Chen, Nuan, et al.
Publicado: (2016) -
Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR
por: Maiese, Kenneth
Publicado: (2016)